Literature DB >> 30054739

Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia.

Erica D Kane1, Vikram Budhraja2, David J Desilets2, John R Romanelli3.   

Abstract

INTRODUCTION: High-resolution esophageal manometry (HREM) is essential in characterizing achalasia subtype and the extent of affected segment to plan the myotomy starting point during per-oral endoscopic myotomy (POEM). However, evidence is lacking that efficacy is improved by tailoring myotomy to the length of the spastic segment on HREM. We sought to investigate whether utilizing HREM to dictate myotomy length in POEM impacts postoperative outcomes.
METHODS: Comparative analysis of HREM-tailored to non-tailored patients from a prospectively collected database of all POEMs at our institution January 2011 through July 2017. A tailored myotomy is defined as extending at least the length of the diseased segment, as initially measured on HREM.
RESULTS: Forty patients were included (11 tailored versus 29 non-tailored). There were no differences in patient age (p = 0.6491) or BMI (p = 0.0677). Myotomy lengths were significantly longer for tailored compared to non-tailored overall (16.6 ± 2.2 versus 13.5 ± 1.8; p < 0.0001), and for only type III achalasia (15.9 ± 2.4 versus 12.7 ± 1.2; p = 0.0453), likely due to more proximal starting position in tailored cases (26.0 ± 2.2 versus 30.0 ± 2.7; p < 0.0001). Procedure success (Eckardt < 3) was equivalent across groups overall (p = 0.5558), as was postoperative Eckardt score (0.2 ± 0.4 versus 0.8 ± 2.3; p = 0.4004). Postoperative Eckardt score was significantly improved in the tailored group versus non-tailored for type III only (0.2 ± 0.4 versus 1.3 ± 1.5; p = 0.0435). A linear correlation was seen between increased length and greater improvement in Eckardt score in the non-tailored group (p = 0.0170).
CONCLUSIONS: Using HREM to inform surgeons of the proximal location of the diseased segment resulted in longer myotomies, spanning the entire affected segment in type III achalasia, and in lower postoperative Eckardt scores. Longer myotomy length is often more easily achieved with POEM than with Heller myotomy, which raises the question of whether POEM results in better outcomes for type III achalasia, as types I and II do not generally have measurable spastic segments.

Entities:  

Keywords:  Eckardt score; High-resolution esophageal manometry; Per-oral endoscopic myotomy; Type III achalasia

Year:  2018        PMID: 30054739     DOI: 10.1007/s00464-018-6356-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  32 in total

Review 1.  Expert consensus document: Advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes.

Authors:  Peter J Kahrilas; Albert J Bredenoord; Mark Fox; C Prakash Gyawali; Sabine Roman; André J P M Smout; John E Pandolfino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

2.  International multicenter experience with peroral endoscopic myotomy for the treatment of spastic esophageal disorders refractory to medical therapy (with video).

Authors:  Mouen A Khashab; Ahmed A Messallam; Manabu Onimaru; Ezra N Teitelbaum; Michael B Ujiki; Matthew E Gitelis; Rani J Modayil; Eric S Hungness; Stavros N Stavropoulos; Mohamad H El Zein; Hironari Shiwaku; Rastislav Kunda; Alessandro Repici; Hitomi Minami; Philip W Chiu; Jeffrey Ponsky; Vivek Kumbhari; Payal Saxena; Amit P Maydeo; Haruhiro Inoue
Journal:  Gastrointest Endosc       Date:  2015-01-26       Impact factor: 9.427

Review 3.  Is POEM the Answer for Management of Spastic Esophageal Disorders? A Systematic Review and Meta-Analysis.

Authors:  Muhammad Ali Khan; Vivek Kumbhari; Saowanee Ngamruengphong; Amr Ismail; Yen-I Chen; Yamile Haito Chavez; Majidah Bukhari; Richard Nollan; Mohammad Kashif Ismail; Manabu Onimaru; Valerio Balassone; Ahmed Sharata; Lee Swanstrom; Haruhiro Inoue; Alessandro Repici; Mouen A Khashab
Journal:  Dig Dis Sci       Date:  2016-11-17       Impact factor: 3.199

4.  Achalasia: incidence, prevalence and survival. A population-based study.

Authors:  D C Sadowski; F Ackah; B Jiang; L W Svenson
Journal:  Neurogastroenterol Motil       Date:  2010-05-11       Impact factor: 3.598

Review 5.  Diagnosis and Treatment Strategy of Achalasia Subtypes and Esophagogastric Junction Outflow Obstruction Based on High-Resolution Manometry.

Authors:  Eikichi Ihara; Kazumasa Muta; Keita Fukaura; Kazuhiko Nakamura
Journal:  Digestion       Date:  2017-01-05       Impact factor: 3.216

6.  The relationship between manometric subtype and outcomes of surgical treatment for patients with achalasia : Achalasia: manometric subtypes.

Authors:  Oscar Maximiliano Crespin; Roger Perry Tatum; Keliang Xiao; Ana Valeria Martin; Saurabh Khandelwal; Carlos Alberto Pellegrini; Brant Kurt Oelschlager
Journal:  Surg Endosc       Date:  2017-04-27       Impact factor: 4.584

7.  Achalasia: a new clinically relevant classification by high-resolution manometry.

Authors:  John E Pandolfino; Monika A Kwiatek; Thomas Nealis; William Bulsiewicz; Jennifer Post; Peter J Kahrilas
Journal:  Gastroenterology       Date:  2008-07-22       Impact factor: 22.682

Review 8.  High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities.

Authors:  J E Pandolfino; M R Fox; A J Bredenoord; P J Kahrilas
Journal:  Neurogastroenterol Motil       Date:  2009-04-22       Impact factor: 3.598

9.  Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation.

Authors:  Nitesh Pratap; Rakesh Kalapala; Santosh Darisetty; Nitin Joshi; Mohan Ramchandani; Rupa Banerjee; Sandeep Lakhtakia; Rajesh Gupta; Manu Tandan; G V Rao; D Nageshwar Reddy
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

10.  Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study.

Authors:  Vivek Kumbhari; Alan H Tieu; Manabu Onimaru; Mohammad H El Zein; Ezra N Teitelbaum; Michael B Ujiki; Matthew E Gitelis; Rani J Modayil; Eric S Hungness; Stavros N Stavropoulos; Hiro Shiwaku; Rastislav Kunda; Philip Chiu; Payal Saxena; Ahmed A Messallam; Haruhiro Inoue; Mouen A Khashab
Journal:  Endosc Int Open       Date:  2015-04-13
View more
  6 in total

Review 1.  Endoscopic and Surgical Treatments for Achalasia: Who to Treat and How?

Authors:  Romulo A Fajardo; Roman V Petrov; Charles T Bakhos; Abbas E Abbas
Journal:  Gastroenterol Clin North Am       Date:  2020-06-26       Impact factor: 3.806

Review 2.  Updated Systematic Review of Achalasia, with a Focus on POEM Therapy.

Authors:  Mitchell S Cappell; Stavros Nicholas Stavropoulos; David Friedel
Journal:  Dig Dis Sci       Date:  2019-08-27       Impact factor: 3.199

3.  Clinical efficacy of per-oral endoscopic myotomy (POEM) for spastic esophageal disorders: a systematic review and meta-analysis.

Authors:  Saurabh Chandan; Babu Pappu Mohan; Ojasvini Choudhry Chandan; Lokesh Kumar Jha; Harmeet Singh Mashiana; Alexander Todd Hewlett; Mouen A Khashab
Journal:  Surg Endosc       Date:  2019-05-09       Impact factor: 4.584

4.  Esophagogastric junction compliance on impedance planimetry (EndoFLIP™) following peroral endoscopic myotomy (POEM) predicts improvement in postoperative eckardt score.

Authors:  Julia R Amundson; Hoover Wu; Vanessa VanDruff; Michelle Campbell; Kristine Kuchta; H Mason Hedberg; Michael B Ujiki
Journal:  Surg Endosc       Date:  2022-07-15       Impact factor: 3.453

5.  Clinical and financial outcomes of per-oral endoscopic myotomy compared to laparoscopic heller myotomy for treatment of achalasia.

Authors:  Lena Shally; Kashif Saeed; Derek Berglund; Mark Dudash; Katie Frank; Vladan N Obradovic; Anthony T Petrick; David L Diehl; Jon D Gabrielsen; David M Parker
Journal:  Surg Endosc       Date:  2022-10-11       Impact factor: 3.453

6.  Changes in the Treatment of Primary Esophageal Motility Disorders Imposed by the New Classification for Esophageal Motility Disorders on High Resolution Manometry (Chicago Classification 4.0).

Authors:  Fernando A M Herbella; Leonardo M Del Grande; Francisco Schlottmann; Marco G Patti
Journal:  Adv Ther       Date:  2021-03-27       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.